Pharma stocks face Q4 reality check Amid Global Headwinds
20 Apr 2026 //
INDPHARMAPOST
Corona Remedies Unveils Wokadine Initiative in India
31 Mar 2026 //
EXPRESSPHARMA
Dr Reddy’s Acquires Progynova, Cyclo-Progynova In India
18 Feb 2026 //
PRESS RELEASE
Dr. Reddy`s Lab: Biopharma Shakti Program Drives India`s Value
01 Feb 2026 //
ECONOMICTIMES
Dr. Reddy’s Q3 & 9MFY26 Financial Results
21 Jan 2026 //
PRESS RELEASE
National Pharmaceutical Pricing Authority Sets Retail Prices
27 Dec 2025 //
PHARMABIZ
Dr. Reddy`s Sets Sbti-Approved Net Zero Target For FY2045
12 Dec 2025 //
EXPRESSPHARMA
Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug
08 Dec 2025 //
PRESS RELEASE
Dr. Reddys Labs Posts Rs. 1,437.2 Cr Q2 FY26 PAT
27 Oct 2025 //
PRESS RELEASE
Dr. Reddy’s Gets Positive CHMP Opinion from EMA for AVT03
22 Sep 2025 //
PRESS RELEASE
Dr Reddy’s Expands CNS Portfolio With Acquisition of Stugeron
10 Sep 2025 //
PRESS RELEASE
Dr. Reddy`s Infuses Rs. 565 Crore in Its Russian Subsidiary
27 Jul 2025 //
INDPHARMAPOST
Dr. Reddy’s re-appoints G V Prasad as Co-Chairman & Director
27 Jul 2025 //
INDPHARMAPOST
Dr. Reddy’s Q1FY26 Financial Results
24 Jul 2025 //
PRESS RELEASE
Dr. Reddy’s Q4 & full year FY25 Financial Results
10 May 2025 //
PRESS RELEASE
Sanofi puts insulin brand Lantus up for sale, eyes Rs 2,000 cr
15 Apr 2025 //
ECONOMICTIMES
Dr Reddy`s cuts jobs by 25%, asks high earners to resign
14 Apr 2025 //
ECONOMICTIMES
Indian pharma stocks decline after Trump again threatens tariffs
09 Apr 2025 //
REUTERS
Dr Reddy`s Lab gets Rs 2,395 crore show notice from IT authority
08 Apr 2025 //
INDPHARMAPOST
Indian pharma stocks `breathe easy` on US tariffs exemption
03 Apr 2025 //
REUTERS
Indian drugmakers resilient against US tariffs: Dr. Reddy`s
25 Feb 2025 //
BUSINESS STD
Indian drugmaker Dr Reddy`s shares slide after Q3 profit miss
24 Jan 2025 //
PRESS RELEASE
Dr. Reddy’s wins CPHI & PMEC India Award for Ancillary Pharma Services
29 Nov 2024 //
PRESS RELEASE
6 pharma companies sign MoUs with Telangana for Pharma City
23 Nov 2024 //
BUSINESS STD
Dr. Reddy’s Q2 & H1 FY25 Financial Results
05 Nov 2024 //
PRESS RELEASE
Dr Reddy`s launches medication to treat chronic constipation
29 Oct 2024 //
PRESS RELEASE
Dr. Reddy`s Launches Menopause Support Program For Employees
14 Oct 2024 //
BUSINESSWIRE
Dr. Reddy`s invests US$ 620 million in Switzerland subsidiary
30 Sep 2024 //
INDPHARMAPOST
UBS advises `selling` a bunch of pharma stocks
27 Sep 2024 //
CNBCTV
Dr Reddy`s Clarifies After Congress Alleges Benefit From Dhaval Buch Connection
11 Sep 2024 //
ECONOMICTIMES
Dr Reddy’s Glycemic Happiness Awareness sets World Record
23 Aug 2024 //
EXPRESSPHARMA
Dr. Reddy`s, Aurigene, & Kainomyx Announce Malaria Drug Partnership
20 Aug 2024 //
PRESS RELEASE
Dr Reddy`s gets EIR from USFDA for Visakhapatnam units
12 Aug 2024 //
ECONOMICTIMES
Dr Reddy`s invests Rs 734 crore in JV with Nestle India
04 Aug 2024 //
ECONOMICTIMES
Dr Reddys Laboratories posts Q1 FY25 consolidated PAT at Rs. 1,392 Cr
29 Jul 2024 //
PRESS RELEASE
Dr. Reddy’s Q1FY25 Financial Results
27 Jul 2024 //
PRESS RELEASE
Dr Reddy`s inks licensing pact with Takeda to sell gastrointestinal drug
20 Jul 2024 //
PRESS RELEASE
Dr. Reddy`s Signs Licensing Deal With Takeda For Vonoprazan
19 Jul 2024 //
PRESS RELEASE
Dr. Reddy`s shares rise as arm signs license agreement with Ingenus Pharma
12 Jun 2024 //
MONEYCONTROL
Dr. Reddy`s: Milan Kalawadia Appointed CEO North America
28 May 2024 //
BUSINESSWIRE
Indian drugmakers to see FY25 revenue boost in key US market
28 May 2024 //
REUTERS
Dr. Reddy’s and Novartis sign distribution agreement for anti-diabetes products
27 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Personalised medicine is a new thing fast gaining momentum: CEO, DRL
24 May 2024 //
PHARMABIZ
India`s Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
11 May 2024 //
REUTERS
Dr Reddy’s to launch over 20 products in US in FY25
08 May 2024 //
MONEYCONTROL
Dr. Reddy’s Q4 & Full Year FY24 Financial Results
07 May 2024 //
PRESS RELEASE
Dr Reddy`s Labs CFO Parag Agarwal to retire on July 31, MV Narasimham elevated
07 May 2024 //
MONEYCONTROL
Dr. Reddy`s launches Doxycycline Capsules, 40 mg in US
03 May 2024 //
PRESS RELEASE
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
28 Apr 2024 //
ECONOMICTIMES
Nestle India profit beats estimates on strong demand; forms JV with Dr. Reddy`s
24 Apr 2024 //
PRESS RELEASE
Dr Reddy`s launches migraine management device in Europe
11 Apr 2024 //
PRESS RELEASE
Dr. Reddy`s Labs partners with Bayer for second brand of Vericiguat for India market
06 Apr 2024 //
PRESS RELEASE
Dr Reddy`s arm rolls AI&ML assisted drug discovery platform Aurigene.AI
04 Apr 2024 //
PRESS RELEASE
Dr. Reddy`s Partners With Sanofi India For Exclusive Vaccine Distribution
27 Mar 2024 //
PRESS RELEASE
Pharmazz & Dr. Reddy`s have entered into a lice agreement to market Centhaquine
22 Mar 2024 //
PRESS RELEASE
Dr. Reddy`s Lab launches Versavo in the UK
20 Mar 2024 //
INDIANPHARMAPOST
Dr Reddy`s gets Rs 74.22 cr tax demand from GST authority
12 Mar 2024 //
ECONOMIC TIMES
Dr Reddy`s Q3 results: Net profit rises 11% to Rs 1,379 cr
30 Jan 2024 //
PRESS RELEASE
Dr Reddy’s Laboratories eyes mega brand in UK
18 Jan 2024 //
FINANCIAL EXPRESS
Dr Reddy`s acquires MenoLabs` women health brands in US
04 Jan 2024 //
PRESS RELEASE

Market Place
Sourcing Support